Tejava Ice Tea Recall Issued Due to Glass Fragment Contamination

A nationwide recall of Tejava Premium Iced Tea has been issued after it was discovered that some 12 oz bottles may be contaminated by glass fragments. 

The Tejava ice tea recall was announced by the FDA on December 9, after the company reported the problems.

Although there have been no reports of illness or injury resulting from the contaminated ice tea bottles, the manufacturer indicates that the glass fragments may be harmful if swallowed.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The recall affects Tejava Premium Iced Tea in 12 oz. glass bottles with production lot code dates of 1BT220, 1BT221, 1BT222, 1BT223, 1BT252, 1BT253, 1BT254, 1BT255, 1BT277, 1BT278, 1BT279, 1BT280, and 1BT313. The production codes can be found on the back of the bottle label and on the long panel of the case tray. The cases the bottles were sold in have a UPC of 6-54871-24901-2, the four-packs have a UPC of 6-54871-04901-1, and the single bottles have a UPC of 6-54871-00901-5. The 1 liter bottles of Tejava Premium Iced Tea are not affected by the recall.

The company is asking consumers to return affected bottles of Tejava Premium Iced Tea to the store where it was purchased. The will receive coupons, product replacement or credit. Consumers with questions can call the Tejava Consumer Hotline at (888) 847-8742 or visit the company’s website at www.Tejava.com.

Tags: Food Recall

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Gardasil Vaccine Lawsuits Being Prepared For Early Test Trials in Federal MDL
Gardasil Vaccine Lawsuits Being Prepared For Early Test Trials in Federal MDL (Posted yesterday)

In advance of a a conference this week, lawyers report that progress is being made to prepare a group of federal Gardasil vaccine lawsuits for early test trials, to help gauge how juries may respond to certain evidence and testimony that will be repeated throughout the litigation.

Enfamil Lawsuit Claims Preemie Developed NEC After Being Fed Cow's Milk-Based Infant Formula
Enfamil Lawsuit Claims Preemie Developed NEC After Being Fed Cow's Milk-Based Infant Formula (Posted 2 days ago)

Cow's milk-based infant formula products are dangerous for premature infants, according to a mother's recent Enfamil lawsuit, filed after her newborn developed necrotizing enterocolitis and suffered through surgery and continuing negative health effects.

Ozempic MDL Lawsuits Reassigned To New Judge For Further Pretrial Proceedings
Ozempic MDL Lawsuits Reassigned To New Judge For Further Pretrial Proceedings (Posted 5 days ago)

All lawsuits over Ozempic, Mounjaro, Wegovy and other GLP-1 RA drugs to U.S. District Judge Karen S. Marston, following the death last month of the judge originally appointed to preside over all claims involving stomach paralysis and other gastrointestinal injuries.